ID   SRPK2_HUMAN             Reviewed;         688 AA.
AC   P78362; A8MVX2; O75220; O75221; Q6NUL0; Q6V1X2; Q8IYQ3;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 3.
DT   12-OCT-2022, entry version 200.
DE   RecName: Full=SRSF protein kinase 2;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:18559500, ECO:0000269|PubMed:9472028, ECO:0000305|PubMed:21157427};
DE   AltName: Full=SFRS protein kinase 2;
DE   AltName: Full=Serine/arginine-rich protein-specific kinase 2;
DE            Short=SR-protein-specific kinase 2;
DE   Contains:
DE     RecName: Full=SRSF protein kinase 2 N-terminal;
DE   Contains:
DE     RecName: Full=SRSF protein kinase 2 C-terminal;
GN   Name=SRPK2 {ECO:0000312|EMBL:AAH68547.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC05299.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Fetal brain {ECO:0000269|PubMed:9472028};
RX   PubMed=9472028; DOI=10.1083/jcb.140.4.737;
RA   Wang H.-Y., Lin W., Dyck J.A., Yeakley J.M., Songyang Z., Cantley L.C.,
RA   Fu X.-D.;
RT   "SRPK2: a differentially expressed SR protein-specific kinase involved in
RT   mediating the interaction and localization of pre-mRNA splicing factors in
RT   mammalian cells.";
RL   J. Cell Biol. 140:737-750(1998).
RN   [2] {ECO:0000312|EMBL:AAC29141.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000312|EMBL:AAQ63886.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000312|EMBL:AAH35214.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 1-99 (ISOFORM 2).
RC   TISSUE=Retinoblastoma, Skin {ECO:0000312|EMBL:AAH35214.1}, and Testis
RC   {ECO:0000312|EMBL:AAH68547.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000312|EMBL:AAQ63886.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-537 (ISOFORM 1).
RC   TISSUE=Testis {ECO:0000312|EMBL:AAQ63886.1};
RA   Sha J.H., Zhou Z.M., Li J.M.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   FUNCTION IN PHOSPHORYLATION OF HEPATITIS B VIRUS CORE PROTEIN, CATALYTIC
RP   ACTIVITY, AND COFACTOR.
RX   PubMed=12134018; DOI=10.1128/jvi.76.16.8124-8137.2002;
RA   Daub H., Blencke S., Habenberger P., Kurtenbach A., Dennenmoser J.,
RA   Wissing J., Ullrich A., Cotten M.;
RT   "Identification of SRPK1 and SRPK2 as the major cellular protein kinases
RT   phosphorylating hepatitis B virus core protein.";
RL   J. Virol. 76:8124-8137(2002).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [8]
RP   FUNCTION IN NEGATIVE REGULATION OF HEPATITIS B VIRUS (HBV) REPLICATION.
RX   PubMed=16122776; DOI=10.1016/j.virol.2005.07.030;
RA   Zheng Y., Fu X.D., Ou J.H.;
RT   "Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a
RT   pathway independent of the phosphorylation of the viral core protein.";
RL   Virology 342:150-158(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-497, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF ACIN1, CATALYTIC ACTIVITY, AND INTERACTION
RP   WITH ACIN1.
RX   PubMed=18559500; DOI=10.1158/0008-5472.can-08-0021;
RA   Jang S.W., Yang S.J., Ehlen A., Dong S., Khoury H., Chen J., Persson J.L.,
RA   Ye K.;
RT   "Serine/arginine protein-specific kinase 2 promotes leukemia cell
RT   proliferation by phosphorylating acinus and regulating cyclin A1.";
RL   Cancer Res. 68:4559-4570(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF DDX23/PRP28, AND ASSOCIATION WITH U4/U6-U5
RP   TRI-SNRNPS.
RX   PubMed=18425142; DOI=10.1038/nsmb.1415;
RA   Mathew R., Hartmuth K., Moehlmann S., Urlaub H., Ficner R., Luehrmann R.;
RT   "Phosphorylation of human PRP28 by SRPK2 is required for integration of the
RT   U4/U6-U5 tri-snRNP into the spliceosome.";
RL   Nat. Struct. Mol. Biol. 15:435-443(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-494 AND SER-497, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   FUNCTION, INTERACTION WITH AKT1; YWHAB; YWHAE AND SFN, SUBCELLULAR
RP   LOCATION, AND PHOSPHORYLATION AT THR-492.
RX   PubMed=19592491; DOI=10.1074/jbc.m109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle
RT   and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380; SER-494 AND SER-497, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   FUNCTION IN PHOSPHORYLATION OF SRSF2, CATALYTIC ACTIVITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21157427; DOI=10.1038/emboj.2010.333;
RA   Edmond V., Moysan E., Khochbin S., Matthias P., Brambilla C., Brambilla E.,
RA   Gazzeri S., Eymin B.;
RT   "Acetylation and phosphorylation of SRSF2 control cell fate decision in
RT   response to cisplatin.";
RL   EMBO J. 30:510-523(2011).
RN   [20]
RP   REVIEW ON FUNCTION.
RX   PubMed=21205200; DOI=10.1111/j.1742-4658.2010.07987.x;
RA   Giannakouros T., Nikolakaki E., Mylonis I., Georgatsou E.;
RT   "Serine-arginine protein kinases: a small protein kinase family with a
RT   large cellular presence.";
RL   FEBS J. 278:570-586(2011).
RN   [21]
RP   FUNCTION, CATALYTIC ACTIVITY, PROTEOLYTIC CLEAVAGE AT ASP-139 AND ASP-403
RP   BY CASPASE-3, AND SUBCELLULAR LOCATION.
RX   PubMed=21056976; DOI=10.1074/jbc.m110.193441;
RA   Hong Y., Jang S.W., Ye K.;
RT   "The N-terminal fragment from caspase-cleaved serine/arginine protein-
RT   specific kinase2 (SRPK2) translocates into the nucleus and promotes
RT   apoptosis.";
RL   J. Biol. Chem. 286:777-786(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-494 AND SER-497, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-494, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-380 AND SER-497, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   FUNCTION, INTERACTION WITH POLR2A, AND SUBCELLULAR LOCATION.
RX   PubMed=28076779; DOI=10.1016/j.celrep.2016.12.050;
RA   Sridhara S.C., Carvalho S., Grosso A.R., Gallego-Paez L.M.,
RA   Carmo-Fonseca M., de Almeida S.F.;
RT   "Transcription Dynamics Prevent RNA-Mediated Genomic Instability through
RT   SRPK2-Dependent DDX23 Phosphorylation.";
RL   Cell Rep. 18:334-343(2017).
RN   [26]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-43; ASP-243; PRO-426; PHE-486 AND
RP   THR-515.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/arginine-rich protein-specific kinase which
CC       specifically phosphorylates its substrates at serine residues located
CC       in regions rich in arginine/serine dipeptides, known as RS domains and
CC       is involved in the phosphorylation of SR splicing factors and the
CC       regulation of splicing (PubMed:9472028, PubMed:18559500,
CC       PubMed:21056976). Promotes neuronal apoptosis by up-regulating cyclin-
CC       D1 (CCND1) expression (PubMed:19592491). This is done by the
CC       phosphorylation of SRSF2, leading to the suppression of p53/TP53
CC       phosphorylation thereby relieving the repressive effect of p53/TP53 on
CC       cyclin-D1 (CCND1) expression (PubMed:21205200). Phosphorylates ACIN1,
CC       and redistributes it from the nuclear speckles to the nucleoplasm,
CC       resulting in cyclin A1 but not cyclin A2 up-regulation
CC       (PubMed:18559500). Plays an essential role in spliceosomal B complex
CC       formation via the phosphorylation of DDX23/PRP28 (PubMed:18425142).
CC       Probably by phosphorylating DDX23, leads to the suppression of
CC       incorrect R-loops formed during transcription; R-loops are composed of
CC       a DNA:RNA hybrid and the associated non-template single-stranded DNA
CC       (PubMed:28076779). Can mediate hepatitis B virus (HBV) core protein
CC       phosphorylation (PubMed:12134018). Plays a negative role in the
CC       regulation of HBV replication through a mechanism not involving the
CC       phosphorylation of the core protein but by reducing the packaging
CC       efficiency of the pregenomic RNA (pgRNA) without affecting the
CC       formation of the viral core particles (PubMed:16122776).
CC       {ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:16122776,
CC       ECO:0000269|PubMed:18425142, ECO:0000269|PubMed:18559500,
CC       ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:21056976,
CC       ECO:0000269|PubMed:21205200, ECO:0000269|PubMed:28076779,
CC       ECO:0000269|PubMed:9472028}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:18559500,
CC         ECO:0000269|PubMed:9472028, ECO:0000305|PubMed:21157427};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:12134018,
CC         ECO:0000269|PubMed:9472028, ECO:0000305|PubMed:21157427};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:9472028};
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on Ser-52 and Ser-
CC       588. {ECO:0000250|UniProtKB:Q96SB4}.
CC   -!- SUBUNIT: Associates with U4/U6-U5 tri-small nuclear ribonucleoproteins
CC       (U4/U6-U5 tri-snRNPs) (PubMed:18425142). Interacts with PKB/AKT1 in a
CC       phosphorylation-dependent manner (PubMed:19592491). The phosphorylated
CC       form (by PKB/AKT1) interacts with YWHAB and YWHAE (PubMed:19592491).
CC       Interaction with YWHAB suppresses its cleavage by caspases and inhibits
CC       the release of its N-terminal pro-apoptotic fragment (PubMed:19592491).
CC       Interacts with SFN (PubMed:19592491). Interacts with ACIN1
CC       (PubMed:18559500). Interacts with POLR2A/RNA polymerase II; the
CC       interaction occurs during the co-transcriptional formation of
CC       inappropriate R-loops (PubMed:28076779). {ECO:0000269|PubMed:18425142,
CC       ECO:0000269|PubMed:18559500, ECO:0000269|PubMed:19592491,
CC       ECO:0000269|PubMed:28076779}.
CC   -!- INTERACTION:
CC       P78362; Q9NWB6: ARGLU1; NbExp=2; IntAct=EBI-593303, EBI-2808785;
CC       P78362; Q66PJ3: ARL6IP4; NbExp=2; IntAct=EBI-593303, EBI-2683099;
CC       P78362; P50613: CDK7; NbExp=2; IntAct=EBI-593303, EBI-1245958;
CC       P78362; Q9Y3Y2: CHTOP; NbExp=2; IntAct=EBI-593303, EBI-347794;
CC       P78362; P49760: CLK2; NbExp=3; IntAct=EBI-593303, EBI-750020;
CC       P78362; P49761: CLK3; NbExp=5; IntAct=EBI-593303, EBI-745579;
CC       P78362; P38432: COIL; NbExp=3; IntAct=EBI-593303, EBI-945751;
CC       P78362; Q7L014: DDX46; NbExp=3; IntAct=EBI-593303, EBI-2555356;
CC       P78362; P51114-2: FXR1; NbExp=3; IntAct=EBI-593303, EBI-11022345;
CC       P78362; P51116: FXR2; NbExp=4; IntAct=EBI-593303, EBI-740459;
CC       P78362; P07910: HNRNPC; NbExp=2; IntAct=EBI-593303, EBI-357966;
CC       P78362; P17509: HOXB6; NbExp=3; IntAct=EBI-593303, EBI-741308;
CC       P78362; Q9NQ29: LUC7L; NbExp=3; IntAct=EBI-593303, EBI-473747;
CC       P78362; Q9Y383: LUC7L2; NbExp=3; IntAct=EBI-593303, EBI-352851;
CC       P78362; Q9P127: LUZP4; NbExp=3; IntAct=EBI-593303, EBI-10198848;
CC       P78362; Q9BU76: MMTAG2; NbExp=3; IntAct=EBI-593303, EBI-742459;
CC       P78362; Q5C9Z4: NOM1; NbExp=3; IntAct=EBI-593303, EBI-2685618;
CC       P78362; Q8NAV1: PRPF38A; NbExp=6; IntAct=EBI-593303, EBI-715374;
CC       P78362; P86480: PRR20D; NbExp=3; IntAct=EBI-593303, EBI-12754095;
CC       P78362; Q86U06: RBM23; NbExp=2; IntAct=EBI-593303, EBI-780319;
CC       P78362; Q14498: RBM39; NbExp=10; IntAct=EBI-593303, EBI-395290;
CC       P78362; Q9Y5S9: RBM8A; NbExp=2; IntAct=EBI-593303, EBI-447231;
CC       P78362; D3DU92: RNPS1; NbExp=3; IntAct=EBI-593303, EBI-10176640;
CC       P78362; Q15287: RNPS1; NbExp=5; IntAct=EBI-593303, EBI-395959;
CC       P78362; Q8TAD8: SNIP1; NbExp=4; IntAct=EBI-593303, EBI-749336;
CC       P78362; Q8WVK2: SNRNP27; NbExp=5; IntAct=EBI-593303, EBI-2512550;
CC       P78362; P08621: SNRNP70; NbExp=4; IntAct=EBI-593303, EBI-1049228;
CC       P78362; Q8WXA9: SREK1; NbExp=2; IntAct=EBI-593303, EBI-1044237;
CC       P78362; Q8IYB3: SRRM1; NbExp=3; IntAct=EBI-593303, EBI-1055880;
CC       P78362; O75494: SRSF10; NbExp=2; IntAct=EBI-593303, EBI-353655;
CC       P78362; Q05519-2: SRSF11; NbExp=3; IntAct=EBI-593303, EBI-11975029;
CC       P78362; Q13243: SRSF5; NbExp=2; IntAct=EBI-593303, EBI-720503;
CC       P78362; Q16629: SRSF7; NbExp=2; IntAct=EBI-593303, EBI-398885;
CC       P78362; Q9BRL6: SRSF8; NbExp=2; IntAct=EBI-593303, EBI-6380719;
CC       P78362; Q9BRL6-2: SRSF8; NbExp=3; IntAct=EBI-593303, EBI-10976394;
CC       P78362; Q13428: TCOF1; NbExp=2; IntAct=EBI-593303, EBI-396105;
CC       P78362; Q08117: TLE5; NbExp=3; IntAct=EBI-593303, EBI-717810;
CC       P78362; Q13595: TRA2A; NbExp=2; IntAct=EBI-593303, EBI-2685506;
CC       P78362; P62995: TRA2B; NbExp=5; IntAct=EBI-593303, EBI-725485;
CC       P78362; Q01081: U2AF1; NbExp=7; IntAct=EBI-593303, EBI-632461;
CC       P78362; Q01081-2: U2AF1; NbExp=3; IntAct=EBI-593303, EBI-10176676;
CC       P78362; P26368: U2AF2; NbExp=5; IntAct=EBI-593303, EBI-742339;
CC       P78362; P26368-2: U2AF2; NbExp=3; IntAct=EBI-593303, EBI-11097439;
CC       P78362; Q96MU7: YTHDC1; NbExp=4; IntAct=EBI-593303, EBI-2849854;
CC       P78362; P31946: YWHAB; NbExp=2; IntAct=EBI-593303, EBI-359815;
CC       P78362; Q15696: ZRSR2; NbExp=7; IntAct=EBI-593303, EBI-6657923;
CC       P78362; O43309: ZSCAN12; NbExp=3; IntAct=EBI-593303, EBI-1210440;
CC       P78362; O15535: ZSCAN9; NbExp=6; IntAct=EBI-593303, EBI-751531;
CC       P78362; P0DTC9: N; Xeno; NbExp=2; IntAct=EBI-593303, EBI-25475856;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21056976,
CC       ECO:0000269|PubMed:21157427, ECO:0000269|PubMed:28076779,
CC       ECO:0000269|PubMed:9472028}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:21157427, ECO:0000269|PubMed:28076779,
CC       ECO:0000269|PubMed:9472028}. Nucleus speckle
CC       {ECO:0000269|PubMed:28076779, ECO:0000269|PubMed:9472028}. Chromosome
CC       {ECO:0000269|PubMed:28076779}. Note=Shuttles between the nucleus and
CC       the cytoplasm (PubMed:19592491, PubMed:21157427, PubMed:21056976).
CC       KAT5/TIP60 inhibits its nuclear translocation (PubMed:21157427).
CC       Phosphorylation at Thr-492 by PKB/AKT1 promotes nuclear translocation
CC       (PubMed:19592491). Preferentially localizes across the entire gene
CC       coding region (PubMed:28076779). During transcription, accumulates at
CC       chromatin loci where unscheduled R-loops form and colocalizes with
CC       paused 'Ser-5'-phosphorlyated POLR2A/RNA polymerase II and helicase
CC       DDX23 (PubMed:28076779). {ECO:0000269|PubMed:19592491,
CC       ECO:0000269|PubMed:21056976, ECO:0000269|PubMed:21157427,
CC       ECO:0000269|PubMed:28076779}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78362-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78362-2; Sequence=VSP_039386;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, moderately expressed in
CC       heart and skeletal muscle and at low levels in lung, liver, and kidney.
CC       {ECO:0000269|PubMed:9472028}.
CC   -!- PTM: Phosphorylation at Thr-492 by PKB/AKT1 enhances its stimulatory
CC       activity in triggering cyclin-D1 (CCND1) expression and promoting
CC       apoptosis in neurons, which can be blocked by YWHAB. It also enhances
CC       its protein kinase activity toward ACIN1 and SRSF2, promotes its
CC       nuclear translocation and prevents its proteolytic cleavage.
CC       {ECO:0000269|PubMed:19592491}.
CC   -!- PTM: Proteolytically cleaved at Asp-139 and Asp-403 by caspase-3 during
CC       apoptotic cell death. Cleavage at Asp-139 which is the major site of
CC       cleavage, produces a small N-terminal fragment that translocates into
CC       nucleus and promotes VP16-induced apoptosis.
CC       {ECO:0000269|PubMed:21056976}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ63886.1; Type=Miscellaneous discrepancy; Note=The cDNA appears to contain a duplicated region.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U88666; AAC05299.1; -; mRNA.
DR   EMBL; AC005070; AAC29140.1; -; Genomic_DNA.
DR   EMBL; AC005070; AAC29141.1; -; Genomic_DNA.
DR   EMBL; AC004884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073138; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471070; EAW83359.1; -; Genomic_DNA.
DR   EMBL; BC035214; AAH35214.1; -; mRNA.
DR   EMBL; BC068547; AAH68547.1; -; mRNA.
DR   EMBL; BE781215; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AY354201; AAQ63886.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS34724.1; -. [P78362-2]
DR   CCDS; CCDS5735.1; -. [P78362-1]
DR   RefSeq; NP_001265202.1; NM_001278273.1. [P78362-1]
DR   RefSeq; NP_872633.1; NM_182691.2. [P78362-1]
DR   RefSeq; NP_872634.1; NM_182692.2. [P78362-2]
DR   RefSeq; XP_016868055.1; XM_017012566.1.
DR   PDB; 2X7G; X-ray; 2.50 A; A=51-688.
DR   PDB; 5MYV; X-ray; 2.90 A; A/B/C/D=51-688.
DR   PDBsum; 2X7G; -.
DR   PDBsum; 5MYV; -.
DR   AlphaFoldDB; P78362; -.
DR   SMR; P78362; -.
DR   BioGRID; 112611; 620.
DR   IntAct; P78362; 385.
DR   MINT; P78362; -.
DR   STRING; 9606.ENSP00000377262; -.
DR   BindingDB; P78362; -.
DR   ChEMBL; CHEMBL5668; -.
DR   DrugBank; DB00173; Adenine.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   DrugBank; DB02733; Purvalanol.
DR   DrugCentral; P78362; -.
DR   MoonDB; P78362; Predicted.
DR   GlyGen; P78362; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P78362; -.
DR   PhosphoSitePlus; P78362; -.
DR   BioMuta; SRPK2; -.
DR   DMDM; 300669676; -.
DR   EPD; P78362; -.
DR   jPOST; P78362; -.
DR   MassIVE; P78362; -.
DR   MaxQB; P78362; -.
DR   PaxDb; P78362; -.
DR   PeptideAtlas; P78362; -.
DR   PRIDE; P78362; -.
DR   ProteomicsDB; 57591; -. [P78362-1]
DR   ProteomicsDB; 57592; -. [P78362-2]
DR   Antibodypedia; 17064; 168 antibodies from 28 providers.
DR   DNASU; 6733; -.
DR   Ensembl; ENST00000357311.7; ENSP00000349863.3; ENSG00000135250.17. [P78362-1]
DR   Ensembl; ENST00000393651.8; ENSP00000377262.3; ENSG00000135250.17. [P78362-2]
DR   Ensembl; ENST00000489828.5; ENSP00000419791.1; ENSG00000135250.17. [P78362-1]
DR   GeneID; 6733; -.
DR   KEGG; hsa:6733; -.
DR   MANE-Select; ENST00000393651.8; ENSP00000377262.3; NM_182692.3; NP_872634.1. [P78362-2]
DR   UCSC; uc003vct.5; human. [P78362-1]
DR   CTD; 6733; -.
DR   DisGeNET; 6733; -.
DR   GeneCards; SRPK2; -.
DR   HGNC; HGNC:11306; SRPK2.
DR   HPA; ENSG00000135250; Tissue enhanced (testis).
DR   MIM; 602980; gene.
DR   neXtProt; NX_P78362; -.
DR   OpenTargets; ENSG00000135250; -.
DR   PharmGKB; PA36130; -.
DR   VEuPathDB; HostDB:ENSG00000135250; -.
DR   eggNOG; KOG1290; Eukaryota.
DR   GeneTree; ENSGT00940000154795; -.
DR   HOGENOM; CLU_000288_81_9_1; -.
DR   InParanoid; P78362; -.
DR   OMA; NTTGKHV; -.
DR   OrthoDB; 290680at2759; -.
DR   PhylomeDB; P78362; -.
DR   TreeFam; TF105334; -.
DR   PathwayCommons; P78362; -.
DR   Reactome; R-HSA-9694631; Maturation of nucleoprotein.
DR   SignaLink; P78362; -.
DR   SIGNOR; P78362; -.
DR   BioGRID-ORCS; 6733; 14 hits in 1083 CRISPR screens.
DR   ChiTaRS; SRPK2; human.
DR   EvolutionaryTrace; P78362; -.
DR   GeneWiki; SRPK2; -.
DR   GenomeRNAi; 6733; -.
DR   Pharos; P78362; Tchem.
DR   PRO; PR:P78362; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P78362; protein.
DR   Bgee; ENSG00000135250; Expressed in sperm and 215 other tissues.
DR   ExpressionAtlas; P78362; baseline and differential.
DR   Genevisible; P78362; HS.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0071889; F:14-3-3 protein binding; ISS:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; ISS:BHF-UCL.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IC:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; IDA:BHF-UCL.
DR   GO; GO:0035063; P:nuclear speck organization; ISS:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IGI:CACAO.
DR   GO; GO:0045787; P:positive regulation of cell cycle; ISS:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:BHF-UCL.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0062176; P:R-loop disassembly; IDA:UniProtKB.
DR   GO; GO:0050684; P:regulation of mRNA processing; IBA:GO_Central.
DR   GO; GO:0048024; P:regulation of mRNA splicing, via spliceosome; TAS:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IDA:UniProtKB.
DR   GO; GO:0000245; P:spliceosomal complex assembly; IDA:UniProtKB.
DR   DisProt; DP02591; -.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Chromosome; Cytoplasm;
KW   Differentiation; Kinase; mRNA processing; mRNA splicing;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..688
FT                   /note="SRSF protein kinase 2"
FT                   /id="PRO_0000086677"
FT   CHAIN           1..139
FT                   /note="SRSF protein kinase 2 N-terminal"
FT                   /id="PRO_0000414751"
FT   CHAIN           140..688
FT                   /note="SRSF protein kinase 2 C-terminal"
FT                   /id="PRO_0000414752"
FT   DOMAIN          81..684
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..65
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          239..277
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          329..444
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          469..501
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..16
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        18..45
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        46..60
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        329..345
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        346..370
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        377..391
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        395..419
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        421..436
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        214
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         87..95
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UPE1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         110
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UPE1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            139..140
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000269|PubMed:21056976"
FT   SITE            403..404
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000269|PubMed:21056976"
FT   MOD_RES         52
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:24275569"
FT   MOD_RES         475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O54781"
FT   MOD_RES         478
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O54781"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O54781"
FT   MOD_RES         486
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O54781"
FT   MOD_RES         490
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O54781"
FT   MOD_RES         492
FT                   /note="Phosphothreonine; by PKB/AKT1"
FT                   /evidence="ECO:0000269|PubMed:19592491"
FT   MOD_RES         494
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         497
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:24275569"
FT   MOD_RES         588
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..13
FT                   /note="MSVNSEKSSSSER -> MSSRKVLAIQARKRRPKREKHPKK (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_039386"
FT   VARIANT         43
FT                   /note="P -> L (in dbSNP:rs34699980)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041114"
FT   VARIANT         243
FT                   /note="G -> D (in a glioblastoma multiforme sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041115"
FT   VARIANT         426
FT                   /note="T -> P (in dbSNP:rs55743527)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041116"
FT   VARIANT         486
FT                   /note="S -> F (in dbSNP:rs56112661)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041117"
FT   VARIANT         515
FT                   /note="P -> T (in dbSNP:rs56017595)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041118"
FT   VARIANT         608
FT                   /note="S -> N (in dbSNP:rs1050413)"
FT                   /id="VAR_060390"
FT   VARIANT         615
FT                   /note="L -> I (in dbSNP:rs1050418)"
FT                   /id="VAR_057111"
FT   CONFLICT        137
FT                   /note="P -> R (in Ref. 4; AAH68547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        236..237
FT                   /note="AT -> P (in Ref. 1; AAC05299)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        521
FT                   /note="A -> R (in Ref. 1; AAC05299)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        601
FT                   /note="H -> L (in Ref. 2; AAC29141)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        608..609
FT                   /note="SI -> KV (in Ref. 2; AAC29141)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        612..616
FT                   /note="HFALS -> KYAML (in Ref. 2; AAC29141)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        621
FT                   /note="R -> K (in Ref. 2; AAC29141)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        625..627
FT                   /note="NRR -> TRK (in Ref. 2; AAC29141)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        640
FT                   /note="S -> G (in Ref. 4; AAH68547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        681
FT                   /note="Missing (in Ref. 1; AAC05299)"
FT                   /evidence="ECO:0000305"
FT   TURN            78..80
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   STRAND          81..89
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   STRAND          91..100
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   TURN            101..104
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   STRAND          105..112
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           116..134
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           140..144
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   STRAND          150..156
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   STRAND          159..166
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           173..179
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   TURN            180..182
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           187..206
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           217..219
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   STRAND          220..222
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           226..233
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           518..520
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   TURN            521..523
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   STRAND          526..528
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           531..533
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           548..550
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           553..557
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           564..579
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           594..606
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           611..614
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           620..623
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   STRAND          630..632
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           641..649
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           653..666
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           671..673
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           677..681
FT                   /evidence="ECO:0007829|PDB:2X7G"
FT   HELIX           684..686
FT                   /evidence="ECO:0007829|PDB:2X7G"
SQ   SEQUENCE   688 AA;  77527 MW;  ACCAF2A887444EC2 CRC64;
     MSVNSEKSSS SERPEPQQKA PLVPPPPPPP PPPPPPLPDP TPPEPEEEIL GSDDEEQEDP
     ADYCKGGYHP VKIGDLFNGR YHVIRKLGWG HFSTVWLCWD MQGKRFVAMK VVKSAQHYTE
     TALDEIKLLK CVRESDPSDP NKDMVVQLID DFKISGMNGI HVCMVFEVLG HHLLKWIIKS
     NYQGLPVRCV KSIIRQVLQG LDYLHSKCKI IHTDIKPENI LMCVDDAYVR RMAAEATEWQ
     KAGAPPPSGS AVSTAPQQKP IGKISKNKKK KLKKKQKRQA ELLEKRLQEI EELEREAERK
     IIEENITSAA PSNDQDGEYC PEVKLKTTGL EEAAEAETAK DNGEAEDQEE KEDAEKENIE
     KDEDDVDQEL ANIDPTWIES PKTNGHIENG PFSLEQQLDD EDDDEEDCPN PEEYNLDEPN
     AESDYTYSSS YEQFNGELPN GRHKIPESQF PEFSTSLFSG SLEPVACGSV LSEGSPLTEQ
     EESSPSHDRS RTVSASSTGD LPKAKTRAAD LLVNPLDPRN ADKIRVKIAD LGNACWVHKH
     FTEDIQTRQY RSIEVLIGAG YSTPADIWST ACMAFELATG DYLFEPHSGE DYSRDEDHIA
     HIIELLGSIP RHFALSGKYS REFFNRRGEL RHITKLKPWS LFDVLVEKYG WPHEDAAQFT
     DFLIPMLEMV PEKRASAGEC LRHPWLNS
//
